US FDA defends safety of U.S. infant formula
Source: Reuters
WASHINGTON, Nov 28 (Reuters) - The U.S. Food and Drug Administration defended the safety of infant formula sold in the United States on Friday despite tests that found the chemical melamine and a related byproduct in two brands. FDA tests found "very low levels" of the industrial chemical melamine in Nestle's <NESN.VX> Good Start Supreme with Iron formula, said Stephen Sundlof, director of the FDA's Center for Food Safety and Applied Nutrition. It also found low levels of cyanuric acid, a byproduct of melamine, in Mead Johnson's Enfamil Lipil with Iron, Sundlof said. Mead Johnson is a unit of Bristol-Myers Squibb <BMY.N>. Those findings "do not raise public health concerns," Sundlof told a conference call. "The domestic supply of infant formula is safe." (Reporting by Susan Heavey)
| AlertNet news is provided by |










